Purchase Order 75F40124P00428

Award Date 9/17/24
Potential Completion Date 9/16/25
Potential Value $21K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Agilent Technologies, Inc. for the acquisition of a triple quadrupole mass spectrometer with gas chromatograph. The contract has a potential value of $305,252.53 and a completion date of October 8, 2022. This award does not have a set-aside designation. Agilent Technologies, a global leader in life sciences and diagnostics, has previously served as a prime contractor and...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., to provide a Lab Instrument 8800 Triple Quadruple Mass Spectrometer. This equipment will assist the FDA with the detection of trace/low-level toxic elements in various foods. The award, valued at $292,625.37, was made under the General Services Administration (GSA) Scientific Equipment and Services...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order for a gas chromatogram-triple quadrupole mass spectrometer (GC-QQQ-MS) system to Agilent Technologies Inc. Customer Service And Sales Division. The order, valued at $209,750.11, was placed under the Scientific Equipment and Services (FSS-66) Multiple Award Schedule contract administered by the General Services Administration. This analytical instrument will support research...
The U.S. Food & Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) awarded a sole source delivery order to Agilent Technologies Inc. Customer Service And Sales Division for the purchase of an Agilent 6475 triple quadrupole mass spectrometer for the Office of Analytics and Outreach (OARSA) at a ceiling value of $249,782.34. This order is placed under the Multiple Award Schedule (MAS) master contract. The work will be performed in Marshallton, Delaware and is expected...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order to Agilent Technologies Inc. Customer Service And Sales Division for annual preventive maintenance and optional maintenance services for a Triple Quadrupole Ultra-High Performance Liquid Chromatography/Mass Spectrometry (LC/MS) system. The award, valued at $189,567.60, has a completion date of April 22, 2024, and is not set aside for any special designation. Agilent Technologies...
This is a $289,697.03 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Agilent Technologies Inc. for the provision of a triple quadrupole mass spectrometer. The award is under the General Services Administration (GSA) Scientific Equipment and Services schedule (FSS-66). Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets that has provided analytical instruments and services to various federal agencies as a...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., for a Gas Chromatograph Mass Selective Detection with Headspace Sampler System. The contract has a potential value of $171,199.26 and a completion date of August 31, 2019. Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price delivery order contract to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of the global life sciences company Agilent Technologies, Inc. The $569,352.73 contract is for the procurement of an LC-triple quadrupole mass spectrometer and a service/maintenance agreement. This contract is not associated with a set-aside program. Agilent, as a prime contractor, has a...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division on May 29, 2020. The $486,643.85 contract is for the delivery of a triple quadrupole mass spectrometer to be used at the agency's location in Silver Spring, Maryland. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, and has provided a range of analytical...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed-price delivery order contract to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., to upgrade a UHPLC system to a single quadrupole LC MS system. The contract, which does not have a set-aside designation, has a potential value of $207,896.24 and a completion date of September 10, 2018. Agilent Technologies Inc. is a global leader in...

The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., for the repair of an Agilent Triple Quadrupole Mass Spectrometer (GCQQQ) model G7001B (S/N: US13145901). The contract has a ceiling value of $21,058.00 and a period of performance through September 16, 2025. No set-aside was used for this award. Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing a wide range of analytical instruments, software, services, and consumables to federal agencies, including the FDA, for research and testing purposes. This purchase order is likely part of the company's broader portfolio of prime contracts and subcontracts with various government agencies to support their scientific and analytical requirements.

Generated 9/18/24, 9:25 AM